alexa Dr. Juan Ding | Harvard Medical School
ISSN: 2157-7536

Journal of Steroids & Hormonal Science
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Dr. Juan Ding

Researcher
Schepens Eye Research Institute
Massachusettes Eye and Ear Institute
Department of Ophthalmology
Harvard Medical School
20 Staniford St, Boston, MA 02114, USA
 
Biography

Dr. Juan Ding received her B.S. degree from Tsinghua University, Beijing, China in 2004. She then studied in the Molecular and Cellular Biology program under the supervision of Dr. John Kopchick at Ohio University and received her Ph.D. in 2009. Her Ph.D. dissertation unraveled biomarkers of growth hormone and aging in a series of mouse models that showed excess or disrupted growth hormone signaling. As a post doctoral research associate, Dr. Ding focused on detecting growth hormone doping and discovered novel biomarkers of recombinant human growth hormone administration in healthy human subjects. Dr. Ding has published many original research articles as well as reviews and a book chapter on growth hormone, aging, proteomics and molecular biology. Currently Dr. Ding is working at Schepens Eye Research Institute at Harvard medical school to unravel the endocrine regulation of meibomian gland in dry eye disease.

Research Interest

Dr. Ding is interested in the endocrine regulation of aging and age-related diseases. Her current research focuses on dry eye disease, which affects 3 million Americans and is more prevalent among the elderly. Specifically, Dr. Ding is interested in unraveling the molecular mechanism of the pathophysiology induced by retinoic acid, with the objective of identifying therapeutic targets to treat dry eye disease.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords